期刊
DRUG DISCOVERY TODAY
卷 27, 期 11, 页码 -出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2022.103352
关键词
Adipokines; Inflammation; Arthritis; Musculoskeletal diseases; Metabolic Syndrome
资金
- Xunta de Galicia (Servizo Galego de Saude, SERGAS) [ISCIII/SER-GAS]
- Instituto de Salud Carlos III (ISCIII) and FEDER [18/00188, CD21/00042, RD21/0002/0025, PI20/00902]
- Xunta de Galicia [IN606A-2020/010]
- Secretaria de Estado de Universidades, Investigacion, Desarrollo e Innovacion, Ministerio de Universidades [FPU2018-04165]
- Research Executive Agency of the European Union [734899]
- Xunta de Galicia, Conselleria de Educacion, Universidade e Formacion Profesional and Conselleria de Economia, Emprego e Industria (GAIN) [GPC IN607B2019/10]
Recent research has shown that adipokines play important roles not only in adipose signaling, but also in musculoskeletal diseases, potentially impacting disease progression and treatment response.
Adipokines are the principal mediators in adipose signaling. Nevertheless, besides their role in energy storage, these molecules can be produced by other cells, such as immune cells or chondrocytes. Given their pleiotropic effects, research over the past few years has also focused on musculoskeletal diseases, showing that these adipokines might have relevant roles in worsening the disease or improving the treatment response. In this review, we summarize recent advances in our understanding of adipokines and their role in the most prevalent musculoskeletal immune and inflammatory disorders.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据